Effects of Lactobacillus fermentum GKF3 on Reducing Smoking and Brain Neurotransmitter Levels: Findings From Animal and Human Studies
ABSTRACT The efficacy of smoking cessation therapies primarily relies on modulating brain dopamine levels. Given the ability of psychobiotics to modulate neurotransmitter release via the gut‐brain axis, this study investigated the potential of Lactobacillus fermentum GKF3 supplementation to reduce s...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Food Frontiers |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/fft2.70033 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849318442182639616 |
|---|---|
| author | You‐Shan Tsai Shan Lin Chin‐Chu Chen Chun‐Hung Chiu Mei‐Chin Mong Shu‐Ling Hu Chi‐Hao Wu |
| author_facet | You‐Shan Tsai Shan Lin Chin‐Chu Chen Chun‐Hung Chiu Mei‐Chin Mong Shu‐Ling Hu Chi‐Hao Wu |
| author_sort | You‐Shan Tsai |
| collection | DOAJ |
| description | ABSTRACT The efficacy of smoking cessation therapies primarily relies on modulating brain dopamine levels. Given the ability of psychobiotics to modulate neurotransmitter release via the gut‐brain axis, this study investigated the potential of Lactobacillus fermentum GKF3 supplementation to reduce smoking in adults. A preliminary physical restraint study in ICR mice demonstrated that 4 weeks of GKF3 gavage significantly elevated brain dopamine and serotonin levels, suggesting potential efficacy in smoking reduction. Subsequently, a randomized, single‐blind, crossover study was conducted with 45 habitual smokers. Each participant provided informed consent and received either a placebo or GKF3 capsule (2.0 × 1010 colony‐forming units [CFU]/day) for 4 weeks, followed by a 2‐week washout period and crossover to the alternate treatment arm for an additional 4 weeks. The primary outcome was daily tobacco exposure, estimated by measuring nicotine and its metabolites (cotinine and trans‐3′‐hydroxycotinine) in urine using LC–MS/MS. Results showed that the GKF3 group had a significantly greater reduction rate (67%, 30/45) in nicotine and its metabolite levels compared to the placebo group (36%, 16/45, p = 0.0031). No significant differences were observed between groups in oxidative stress parameters before or after the intervention (p > 0.05). In conclusion, supplementation with L. fermentum GKF3 effectively reduces smoking, potentially through the modulation of monoamine neurotransmitters in the brain. This study provides initial evidence supporting the use of probiotics as a complementary therapy for smoking cessation. |
| format | Article |
| id | doaj-art-fb78d84ccc4e4279935818d936333892 |
| institution | Kabale University |
| issn | 2643-8429 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Wiley |
| record_format | Article |
| series | Food Frontiers |
| spelling | doaj-art-fb78d84ccc4e4279935818d9363338922025-08-20T03:50:49ZengWileyFood Frontiers2643-84292025-07-01642065207510.1002/fft2.70033Effects of Lactobacillus fermentum GKF3 on Reducing Smoking and Brain Neurotransmitter Levels: Findings From Animal and Human StudiesYou‐Shan Tsai0Shan Lin1Chin‐Chu Chen2Chun‐Hung Chiu3Mei‐Chin Mong4Shu‐Ling Hu5Chi‐Hao Wu6Biotech Research Institute Grape King Bio Ltd Taoyuan City TaiwanBiotech Research Institute Grape King Bio Ltd Taoyuan City TaiwanBiotech Research Institute Grape King Bio Ltd Taoyuan City TaiwanResearch Institute of Biotechnology Hungkuang University Taichung TaiwanDepartment of Food Nutrition and Health Biotechnology Asia University Taichung TaiwanGraduate Program of Nutrition Science, School of Life Science National Taiwan Normal University Taipei TaiwanGraduate Program of Nutrition Science, School of Life Science National Taiwan Normal University Taipei TaiwanABSTRACT The efficacy of smoking cessation therapies primarily relies on modulating brain dopamine levels. Given the ability of psychobiotics to modulate neurotransmitter release via the gut‐brain axis, this study investigated the potential of Lactobacillus fermentum GKF3 supplementation to reduce smoking in adults. A preliminary physical restraint study in ICR mice demonstrated that 4 weeks of GKF3 gavage significantly elevated brain dopamine and serotonin levels, suggesting potential efficacy in smoking reduction. Subsequently, a randomized, single‐blind, crossover study was conducted with 45 habitual smokers. Each participant provided informed consent and received either a placebo or GKF3 capsule (2.0 × 1010 colony‐forming units [CFU]/day) for 4 weeks, followed by a 2‐week washout period and crossover to the alternate treatment arm for an additional 4 weeks. The primary outcome was daily tobacco exposure, estimated by measuring nicotine and its metabolites (cotinine and trans‐3′‐hydroxycotinine) in urine using LC–MS/MS. Results showed that the GKF3 group had a significantly greater reduction rate (67%, 30/45) in nicotine and its metabolite levels compared to the placebo group (36%, 16/45, p = 0.0031). No significant differences were observed between groups in oxidative stress parameters before or after the intervention (p > 0.05). In conclusion, supplementation with L. fermentum GKF3 effectively reduces smoking, potentially through the modulation of monoamine neurotransmitters in the brain. This study provides initial evidence supporting the use of probiotics as a complementary therapy for smoking cessation.https://doi.org/10.1002/fft2.70033dopaminenicotineprobioticspsychobioticsserotoninsmoking cessation |
| spellingShingle | You‐Shan Tsai Shan Lin Chin‐Chu Chen Chun‐Hung Chiu Mei‐Chin Mong Shu‐Ling Hu Chi‐Hao Wu Effects of Lactobacillus fermentum GKF3 on Reducing Smoking and Brain Neurotransmitter Levels: Findings From Animal and Human Studies Food Frontiers dopamine nicotine probiotics psychobiotics serotonin smoking cessation |
| title | Effects of Lactobacillus fermentum GKF3 on Reducing Smoking and Brain Neurotransmitter Levels: Findings From Animal and Human Studies |
| title_full | Effects of Lactobacillus fermentum GKF3 on Reducing Smoking and Brain Neurotransmitter Levels: Findings From Animal and Human Studies |
| title_fullStr | Effects of Lactobacillus fermentum GKF3 on Reducing Smoking and Brain Neurotransmitter Levels: Findings From Animal and Human Studies |
| title_full_unstemmed | Effects of Lactobacillus fermentum GKF3 on Reducing Smoking and Brain Neurotransmitter Levels: Findings From Animal and Human Studies |
| title_short | Effects of Lactobacillus fermentum GKF3 on Reducing Smoking and Brain Neurotransmitter Levels: Findings From Animal and Human Studies |
| title_sort | effects of lactobacillus fermentum gkf3 on reducing smoking and brain neurotransmitter levels findings from animal and human studies |
| topic | dopamine nicotine probiotics psychobiotics serotonin smoking cessation |
| url | https://doi.org/10.1002/fft2.70033 |
| work_keys_str_mv | AT youshantsai effectsoflactobacillusfermentumgkf3onreducingsmokingandbrainneurotransmitterlevelsfindingsfromanimalandhumanstudies AT shanlin effectsoflactobacillusfermentumgkf3onreducingsmokingandbrainneurotransmitterlevelsfindingsfromanimalandhumanstudies AT chinchuchen effectsoflactobacillusfermentumgkf3onreducingsmokingandbrainneurotransmitterlevelsfindingsfromanimalandhumanstudies AT chunhungchiu effectsoflactobacillusfermentumgkf3onreducingsmokingandbrainneurotransmitterlevelsfindingsfromanimalandhumanstudies AT meichinmong effectsoflactobacillusfermentumgkf3onreducingsmokingandbrainneurotransmitterlevelsfindingsfromanimalandhumanstudies AT shulinghu effectsoflactobacillusfermentumgkf3onreducingsmokingandbrainneurotransmitterlevelsfindingsfromanimalandhumanstudies AT chihaowu effectsoflactobacillusfermentumgkf3onreducingsmokingandbrainneurotransmitterlevelsfindingsfromanimalandhumanstudies |